Dana dhuwit perusahaan myomo.com (MYO)

Logo grafis Myomo, Inc. (MYO)

Cash and cash equivalents demonstrate liquidity dynamics, where 0.01 reflects the baseline level of the metric. Myomo, Inc. (MYO) generates revenue through the sale of innovative MyoPro exoskeletons. Paul Goodinis's effective management is expanding insurance coverage for the products. The uniqueness of the technologies provides significant pricing power, while government payment support stimulates growth in business margins.

Myomo Inc. - Sisa dhuwit perusahaan MYO (periode 04.07.2022 - 21.11.2026)

MYO (Myomo, Inc): rincian analitis lan laporan miturut indikator

Analisis komprehensif perusahaan:myomo.com
Produk mawa merek Myomo Inc.

Liquid asset volume serves as an indicator of internal financial stability, allowing for an assessment of management's ability to sustain operations without resorting to expensive debt capital. For Myomo, Inc. (MYO), the cash trajectory demonstrates the scaling efficiency of the insurance reimbursement system in the US, where resource accumulation coupled with narrow product specialization signals a transition toward a stable recurring revenue model and a reduction in investment risks.

Pesaing utama

Volume dana dhuwit perusahaan BSX|Dana dhuwit perusahaan EW (Edwards Lifesciences Corporation)|Dana dhuwit perusahaan ResMed RMD|Volume dana dhuwit perusahaan Insulet Corp PODD|ZBH: Dhuwit awis perusahaan|Sisa dhuwit perusahaan COO (CooperVision)|ALGN (Align Technology, Inc.) - Dhuwit awis perusahaan|Globus Medical, Inc. - Sisa dhuwit perusahaan|TMDX (TransMedics Group Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alphatec Holdings ATEC|Dana dhuwit perusahaan CryoLife (AORT)|Enovis Corporation (ENOV) - Posisi dhuwit perusahaan|Integra LifeSciences Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Establishment Labs ESTA|Beta Bionics, Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan IRADIMED Corp IRMD|Embecta (EMBC) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan TNDM (Tandem Corp)|Dana dhuwit perusahaan axogeninc.com|Dhuwit awis perusahaan SI-BONE, Inc. (SIBN)|Volume dana dhuwit perusahaan OFIX|Bioventus Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan orthopediatrics.com KIDS|TMCI: Dhuwit awis lan setara dhuwit awis perusahaan|SRTA: Dhuwit awis perusahaan|Carlsmed Inc - Gunggung dana dhuwit perusahaan|RxSight (RXST) - Dana dhuwit perusahaan|Dhuwit awis perusahaan ClearPoint|Dhuwit awis perusahaan STXS|Cadangan dhuwit perusahaan Neuronetics, Inc. STIM|Volume dana dhuwit perusahaan SGHT|Dhuwit awis perusahaan Orchestra BioMed OBIO|Dana dhuwit perusahaan Anika Therapeutics Inc. ANIK|NSPR (InspireMD) - Total volume dana dhuwit perusahaan|ZJYL - Dana dhuwit perusahaan|VANI (vivani.com) - Dhuwit awis lan setara dhuwit awis perusahaan|XTNT (Xtant Medical Inc) - Dhuwit awis perusahaan|Cadangan dhuwit perusahaan n1mtc.com (NMTC)|Dana dhuwit perusahaan modular-medical.com|Dhuwit awis perusahaan Envoy Medical (COCH)|Volume dana dhuwit perusahaan VVOS|NVNO (enVVeno Corp) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SINT (Sintx Technologies)|TNON: Dhuwit awis lan setara dhuwit awis perusahaan|Lifeward - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AMIX (Autonomix Medical)|IVF: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bone Biologics Corporation BBLG|Dhuwit awis perusahaan AXNX|BIOLASE, Inc. (BIOL) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)